For the Inventor, By the Inventor

Enter assignee name

Mountain View, CA, United States of America

Medimmune Vaccines, Inc.

Calculating rank

USPTO Granted Patents = 23

% Expired Patents = 26.1

EPO Patents = 3

Trademarks = 1

Forward Citations = 336

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Vu Truong-Le (5 out of 18 patents)

Kathleen L Coelingh (5 out of 9 patents)

Aurelia Haller (4 out of 15 patents)

4. Richard R Spaete (4 out of 25 patents)

5. Neil T Parkin (3 out of 22 patents)

6. Roderick Tang (3 out of 7 patents)

7. Binh Pham (2 out of 12 patents)

8. Hong Jin (2 out of 24 patents)

9. Martin L Bryant (2 out of 27 patents)

10. Shengqiang Li (2 out of 3 patents)

11. Tai-An Cha (2 out of 12 patents)

12. George William Kemble (2 out of 41 patents)

13. Peter M Palese (2 out of 83 patents)

14. Adolfo Garcia-Sastre (1 out of 72 patents)

15. Richard Schwartz (1 out of 21 patents)

23 patents: Sort by Forward Citations

1. 8722341 - Metapneumovirus strains and their use in vaccine formulations and sequences (2014-05-13),

2. 8012507 - Preservation of bioactive materials by spray drying (2011-09-06),

3. 7381425 - Preservation of bioactive materials by freeze dried foam (2008-06-03),

4. 7378110 - High pressure spray-dry of bioactive materials (2008-05-27),

5. 7341729 - Recombinant parainfluenza virus expression systems and vaccines (2008-03-11),

6. 7276356 - Recombinant negative strand RNA virus expression systems and vaccines (2007-10-02),

7. 7262045 - Methods of producing influenza vaccine compositions (2007-08-28),

8. 7258873 - Preservation of bioactive materials by spray drying (2007-08-21),

9. 7238481 - Recombinant parainfluenza virus expression systems and vaccines (2007-07-03),

10. 7208165 - Human cytomegalovirus DNA sequences (2007-04-24),

11. 7205013 - Recombinant RSV virus expression systems and vaccines (2007-04-17),

12. 7204990 - Attenuation of cytomegalovirus virulence (2007-04-17),

13. 7135180 - Preservation of bioactive materials by freeze dried foam (2006-11-14),

14. 6974686 - Recombinant tryptophan mutants of influenza (2005-12-13),

15. 6887699 - Recombinant negative strand RNA virus expression systems and vaccines (2005-05-03),

Company Overview

Medimmune Vaccines, Inc., based in Mountain View, California, specializes in the development and manufacturing of innovative vaccines. The company focuses on advancing immunotherapy solutions to combat infectious diseases and enhance public health. With a commitment to research and development, Medimmune leverages cutting-edge technologies to create effective vaccine candidates. Its efforts are aimed at addressing unmet medical needs and improving health outcomes on a global scale.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

23 Patents

#133 in Mountain View, CA

#3,424 in California

#14,447 in US

#27,717 in the World

Mountain View, CA, United States of America

Medimmune Vaccines, Inc.

Forward Citations = 336

26 inventors:

Vu Truong-Le (5 out of 18 patents)

Kathleen L Coelingh (5 out of 9 patents)

Aurelia Haller (4 out of 15 patents)

4. Richard R Spaete (4 out of 25 patents)

5. Neil T Parkin (3 out of 22 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Medimmune Vaccines, Inc.. Retrieved from https://idiyas.com/company/medimmune-vaccines

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…